| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adoptive cellular immunotherapy for the treatment of malignant gliomas
|
Hayes, Roberta L
|
|
2001
|
39 |
1-2 |
p. 31-42
12 p.
|
article
|
| 2 |
Antiangiogenic agents and their promising potential in combined therapy
|
Burke, Patricia A
|
|
2001
|
39 |
1-2 |
p. 155-171
17 p.
|
article
|
| 3 |
Anti-idiotypic antibody and recombinant antigen vaccines in colorectal cancer patients
|
Birebent, Brigitte
|
|
2001
|
39 |
1-2 |
p. 107-113
7 p.
|
article
|
| 4 |
A rapid method to identify cytotoxic T-lymphocyte peptide epitopes from HLA-A2 (+) donors
|
Castellanos, Mario R
|
|
2001
|
39 |
1-2 |
p. 133-138
6 p.
|
article
|
| 5 |
Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin™ radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma
|
Wiseman, Gregory A
|
|
2001
|
39 |
1-2 |
p. 181-194
14 p.
|
article
|
| 6 |
IgA antibodies for cancer therapy
|
Dechant, Michael
|
|
2001
|
39 |
1-2 |
p. 69-77
9 p.
|
article
|
| 7 |
Immunocytochemical detection of leukocyte-associated and apoptosis-related antigen expression in childhood brain tumors
|
Bodey, Bela
|
|
2001
|
39 |
1-2 |
p. 3-16
14 p.
|
article
|
| 8 |
Introduction 2000
|
Goldenberg, David M
|
|
2001
|
39 |
1-2 |
p. 1-
1 p.
|
article
|
| 9 |
In vitro and preclinical targeted alpha therapy for melanoma, breast, prostate and colorectal cancers
|
Allen, B.J
|
|
2001
|
39 |
1-2 |
p. 139-146
8 p.
|
article
|
| 10 |
In vivo transfection and/or cross-priming of dendritic cells following DNA and adenoviral immunizations for immunotherapy of cancer—changes in peripheral mononuclear subsets and intracellular IL-4 and IFN-γ lymphokine profile
|
Mincheff, M.
|
|
2001
|
39 |
1-2 |
p. 125-132
8 p.
|
article
|
| 11 |
Localization of pancreatic cancer with radiolabeled monoclonal antibody PAM4
|
Gold, David V.
|
|
2001
|
39 |
1-2 |
p. 147-154
8 p.
|
article
|
| 12 |
Molecular targeting of malignant gliomas with novel multiply-mutated interleukin 13-based cytotoxins
|
Nash, Kevin T.
|
|
2001
|
39 |
1-2 |
p. 87-98
12 p.
|
article
|
| 13 |
Non-myeloablative allogeneic stem cell transplantation focusing on immunotherapy of life-threatening malignant and non-malignant diseases
|
Slavin, Shimon
|
|
2001
|
39 |
1-2 |
p. 25-29
5 p.
|
article
|
| 14 |
Role of radiation dosimetry in radioimmunotherapy planning and treatment dosing
|
DeNardo, Gerald L.
|
|
2001
|
39 |
1-2 |
p. 203-218
16 p.
|
article
|
| 15 |
Short-term autologous tumor cell lines for the active specific immunotherapy of patients with metastatic melanoma
|
Dillman, Robert O
|
|
2001
|
39 |
1-2 |
p. 115-123
9 p.
|
article
|
| 16 |
Specifically targeting the CD22 receptor of human B-cell lymphomas with RNA damaging agents
|
Newton, Dianne L
|
|
2001
|
39 |
1-2 |
p. 79-86
8 p.
|
article
|
| 17 |
Successful therapy of a human lung cancer xenograft using MAb RS7 labeled with residualizing radioiodine
|
Stein, Rhona
|
|
2001
|
39 |
1-2 |
p. 173-180
8 p.
|
article
|
| 18 |
Susceptibility of B-cell lymphoma to human antibodies encoded by the V4-34 gene
|
Bhat, Neelima M
|
|
2001
|
39 |
1-2 |
p. 59-68
10 p.
|
article
|
| 19 |
The role of radiolabeled antibodies in the treatment of non-Hodgkin's lymphoma: the coming of age of radioimmunotherapy
|
M. Goldenberg, David
|
|
2001
|
39 |
1-2 |
p. 195-201
7 p.
|
article
|
| 20 |
The use of Shiga-like toxin 1 in cancer therapy
|
Gariépy, Jean
|
|
2001
|
39 |
1-2 |
p. 99-106
8 p.
|
article
|
| 21 |
Treatment of refractory recurrent malignant glioma with adoptive cellular immunotherapy: a case report
|
Huang, Yiwu
|
|
2001
|
39 |
1-2 |
p. 17-23
7 p.
|
article
|
| 22 |
Vector-driven hyperexpression of a triad of costimulatory molecules confers enhanced T-cell stimulatory capacity to DC precursors
|
Rad, Ariel N
|
|
2001
|
39 |
1-2 |
p. 43-57
15 p.
|
article
|
Journal description